Patients featured are compensated by ViiV Healthcare.

*Based on Studies 1 and 2 (patients new to treatment) and Study 3 (patients replacing their current treatment). DOVATO was compared to a 3- or 4-drug regimen to measure the % of patients with and without an undetectable viral load (less than 50 copies/mL).

*Based on Studies 1 and 2 (patients new to treatment) and Study 3 (patients replacing their current treatment). DOVATO was compared to a 3- or 4-drug regimen to measure the % of patients with and without an undetectable viral load (less than 50 copies/mL).

PMUS-DLLWCNT250012